FUSION PROTEIN CONTAINING HUMAN LEFTY A PROTEIN VARIANTS AND ITS USE Russian patent published in 2023 - IPC C07K14/495 C07K19/00 A61K38/18 A61K47/64 A61K47/68 A61P21/00 A61P21/04 

Abstract RU 2793631 C2

FIELD: biotechnology.

SUBSTANCE: invention is related specifically to therapeutic proteins based on the human protein Lefty A, and can be used in medicine to prevent or treat a neuromuscular disease. A variant of the human Lefty A protein was constructed containing the amino acid sequence L22 to P366 of SEQ ID NO: 131 with a substitution of one or more amino acid residues at processing sites selected from the group consisting of R74G, R77G or R77V, R132G and R135G; and replacing one or more amino acid residues in the propeptide domain selected from the group consisting of E24G, S38K, V42T, K50E, A55T, V63A and R66Q. A fusion protein with Fc or albumin was also obtained based on this human Lefty A variant.

EFFECT: invention provides for the production of variant proteins with the activity of the human Lefty A protein, which have better stability than the native human Lefty A protein and thus are expressed at high levels and produced in high yield in CHO cells.

18 cl, 23 dwg, 16 tbl, 18 ex

Similar patents RU2793631C2

Title Year Author Number
BINDING OF FUSED PROTEIN TO CD47 PROTEIN AND ITS USE 2019
  • Lv, Ming
  • Ding, Xiaoran
  • Miao, Shiwei
  • Tan, Bin
  • Wang, Xuegong
RU2787521C2
THERAPEUTIC FUSION PROTEINS 2020
  • Irigaray, Sebastien
  • Klein, Laurent
  • Skegro, Darko
  • Villani, Marco
  • Welzenbach, Karl
RU2825292C1
RECOMBINANT PROTEINS WITH CCN DOMAINS AND FUSION PROTEINS 2020
  • Attramadal, Khovard
  • Kaasbell, Ole Jorgen
RU2825102C2
PHARMACEUTICAL COMPOSITION FOR TREATING AND/OR PREVENTING MALIGNANT TUMOUR 2016
  • Okano, Fumiyoshi
  • Fujita, Takayuki
  • Chon, Hyongi
  • Kurihara, Akira
RU2714205C2
FUSED PROTEIN CONSTRUCTS FOR COMPLEMENT-RELATED DISEASE 2019
  • Kertis, Majkl Stiven
  • Storek, Majkl
  • Vajolett, Sheliya Mari
  • Kalled, Syuzan L.
  • Fakhnou, Kelli S.
  • Khuan, Chen Zhan
  • Stark, Ellen Garber
  • Tejlor, Frederik Robbins
  • Karavella, Dzhastin Endryu
  • Kholers, Vernon Majkl
RU2824402C2
FUSED PROTEINS WITH ALBUMIN-BINDING DOMAINS 2018
  • Sini, Dzhon, K.
  • Khuan, Khaomin
RU2786444C2
POLYVALENT AND POLYSPECIFIC OX40-BINDING FUSED PROTEINS 2017
  • Ekelman Brendan P.
  • Timmer Dzhon K.
  • Khata Chelsi
  • Dzhons Kajl S.
  • Khussejn Abrakhim
  • Razai Amir S.
  • Beklund Brajan
  • Pandit Radzhaj
  • Kaplan Majk
  • Reskon Lukas
  • Devero Kuinn
RU2773052C2
PHARMACEUTICAL COMPOSITION, INCLUDING A PH20 VARIANT OF HUMAN HYALURONIDASE, AND A MEDICINAL PRODUCT FOR SUBCUTANEOUS ADMINISTRATION 2020
  • Park, Soon Jae
  • Chung, Hye-Shin
  • Lee, Seung Joo
  • Kim, Kyuwan
  • Byun, Minsoo
  • Nam, Ki Seok
RU2810952C2
NOVEL FUSION PROTEINS SPECIFIC FOR CD137 AND GPC3 2020
  • Bel Aiba, Rachida Siham
  • Bossenmaier, Birgit
  • Jaquin, Thomas
  • Peper-Gabriel, Janet
  • Hansbauer, Eva-Maria
  • Schlosser, Corinna
  • Olwill, Shane
RU2814653C2
TGFβR2 MOLECULE WITH TRUNCATED EXTRACELLULAR DOMAIN, FUSION PROTEIN OF TGFβR2 MOLECULE WITH TRUNCATED EXTRACELLULAR DOMAIN, AND ANTI-EGFR ANTIBODIES, AND ANTI-TUMOUR USE OF FUSED PROTEIN 2021
  • Shie Lianzy
  • San Chanjen
  • Guo Erong
RU2824199C1

RU 2 793 631 C2

Authors

Chon, Sun-Yun

Li, Kyun U

Mun, Son Ke

Kan, Sun Chon

Chkhve, Pen-Ok

Kvak, Chon

Chan, Chon Uk

Kim, Chon Khen

Dates

2023-04-04Published

2019-12-17Filed